Literature DB >> 33577790

Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life.

Elena Martínez-Plaza1, Alberto López-Miguel2, Alberto López-de la Rosa3, Colm McAlinden4, Itziar Fernández3, Miguel J Maldonado1.   

Abstract

PURPOSE: To assess the effect of EVO+ (V5) Visian implantable collamer lens implantation on mesopic visual performance, quality of vision (QoV), and quality of life (QoL).
DESIGN: Prospective interventional case series.
METHODS: Thirty-six eyes of 36 participants who underwent EVO+ implantation for myopia were evaluated preoperatively and at postoperative visits at 1 week and 1, 3, and 6 months. Visual acuity (VA) and mesopic contrast sensitivity (CS) with and without halogen- and xenon-type glare sources were evaluated at each visit. Subjective QoV was assessed with the QoV questionnaire and QoL assessed with the Quality of Life Impact of Refractive Correction (QIRC) questionnaire at each visit. Ring-shaped dysphotopsia was also assessed at each postoperative visit. Linear, cumulative link and logit mixed models were fitted to analyze the effect of the EVO+.
RESULTS: Following EVO+ implantation, VA significantly (P ≤ .012) improved at the 4 postoperative visits. Mesopic CS progressively improved at 1, 3, and 6 months postoperatively (P ≤ .012). Halogen glare CS decreased at 1 week and halogen and xenon glare CS improved at 6 months (P ≤ .016). Photostress recovery time after halogen glare improved at 3 and 6 months (P ≤ .004). QoV scores improved at 1 week and 3 and 6 months (P ≤ .001). QIRC scores improved postoperatively (P < .001). Ring-shaped dysphotopsia decreased at 3 and 6 months (P ≤ .007).
CONCLUSIONS: EVO+ implantation provides good mesopic visual performance, QoV, and QoL during up to 6 months follow-up. Some activities performed under mesopic conditions with glare sources may be affected during the first postoperative week. Ring-shaped dysphotopsia is negligibly bothersome 6 months after surgery.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33577790     DOI: 10.1016/j.ajo.2021.02.005

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Inter-eye and postoperative prediction of vault after implantation of EVO + Visian phakic implantable collamer lens.

Authors:  Elena Martínez-Plaza; Alberto López-Miguel; Alberto López-de la Rosa; Miguel J Maldonado
Journal:  Int Ophthalmol       Date:  2022-10-19       Impact factor: 2.029

2.  A Comprehensive Investigation of Contrast Sensitivity and Disk Halo in High Myopia Treated With SMILE and EVO Implantable Collamer Lens Implantation.

Authors:  Wuxiao Zhao; Jing Zhao; Tian Han; Jifang Wang; Zhe Zhang; Xingtao Zhou
Journal:  Transl Vis Sci Technol       Date:  2022-04-01       Impact factor: 3.048

3.  Mesopic Disability Glare in Stage-Two Dysfunctional Lens Syndrome.

Authors:  Alfredo Holgueras; Manuel Marcos; Elena Martínez-Plaza; Alberto López-Miguel; Alberto Mansilla; Miguel J Maldonado
Journal:  Ophthalmol Ther       Date:  2022-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.